CLINICAL_TRIALS
research
· 2025-04-10
Clinical Trial Update: Amivantamab in Adenoid Cystic Carcinoma [Phase 2]
Summary
A Phase 2 trial of amivantamab for adenoid cystic carcinoma (salivary gland cancer) is active but not recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Trisha Wise-Draper | Conditions: Salivary Gland Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING